Annual Total Debt
$97.61 M
+$89.52 M+1106.81%
December 31, 2023
Summary
- As of February 7, 2025, AUPH annual total debt is $97.61 million, with the most recent change of +$89.52 million (+1106.81%) on December 31, 2023.
- During the last 3 years, AUPH annual total debt has risen by +$89.20 million (+1061.02%).
- AUPH annual total debt is now at all-time high.
Performance
AUPH Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$87.85 M
+$1.87 M+2.17%
September 30, 2024
Summary
- As of February 7, 2025, AUPH quarterly total debt is $87.85 million, with the most recent change of +$1.87 million (+2.17%) on September 30, 2024.
- Over the past year, AUPH quarterly total debt has increased by +$1.87 million (+2.17%).
- AUPH quarterly total debt is now -13.20% below its all-time high of $101.21 million, reached on June 30, 2023.
Performance
AUPH Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
AUPH Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1106.8% | +2.2% |
| 3 y3 years | +1061.0% | +972.9% |
| 5 y5 years | +100.0% | +972.9% |
AUPH Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1106.8% | -13.2% | +1007.7% |
| 5 y | 5-year | at high | -100.0% | -13.2% | -100.0% |
| alltime | all time | at high | -100.0% | -13.2% | -100.0% |
Aurinia Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $87.85 M(+2.2%) |
| Jun 2024 | - | $85.98 M(-2.9%) |
| Mar 2024 | - | $88.54 M(-9.3%) |
| Dec 2023 | $97.61 M(+1106.8%) | $97.61 M(+4.7%) |
| Sep 2023 | - | $93.21 M(-7.9%) |
| Jun 2023 | - | $101.21 M(+1176.1%) |
| Mar 2023 | - | $7.93 M(-1.9%) |
| Dec 2022 | $8.09 M(-7.4%) | $8.09 M(-1.2%) |
| Sep 2022 | - | $8.19 M(-2.3%) |
| Jun 2022 | - | $8.38 M(-2.2%) |
| Mar 2022 | - | $8.57 M(-1.9%) |
| Dec 2021 | $8.74 M(+3.9%) | $8.74 M(-1.9%) |
| Sep 2021 | - | $8.91 M(-0.3%) |
| Jun 2021 | - | $8.94 M(+0.6%) |
| Mar 2021 | - | $8.88 M(+5.6%) |
| Dec 2020 | $8.41 M(>+9900.0%) | $8.41 M(+1.3%) |
| Sep 2020 | - | $8.30 M(>+9900.0%) |
| Jun 2020 | - | $0.00(-100.0%) |
| Mar 2020 | - | $5.85 M(>+9900.0%) |
| Dec 2019 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2019 | - | $378.00 K(-8.3%) |
| Jun 2019 | - | $412.00 K(-2.1%) |
| Mar 2019 | - | $421.00 K(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2013 | - | $7800.00(-65.8%) |
| Jun 2013 | - | $22.80 K(-17.1%) |
| Mar 2013 | - | $27.50 K(>+9900.0%) |
| Dec 2012 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2012 | - | $48.80 K(-15.9%) |
| Jun 2012 | - | $58.00 K(-17.4%) |
| Mar 2012 | - | $70.20 K(-11.6%) |
| Dec 2011 | $79.40 K | $79.40 K(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2010 | - | $440.90 K(>+9900.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(-100.0%) |
| Jun 2009 | - | $56.90 K(-98.4%) |
| Mar 2009 | - | $3.57 M(-72.3%) |
| Dec 2008 | $12.88 M(+1770.3%) | $12.88 M(+0.2%) |
| Sep 2008 | - | $12.86 M(-0.9%) |
| Jun 2008 | - | $12.97 M(+4567.2%) |
| Mar 2008 | - | $277.90 K(-59.6%) |
| Dec 2007 | $688.70 K(-70.5%) | $688.70 K(-34.4%) |
| Sep 2007 | - | $1.05 M(-28.7%) |
| Jun 2007 | - | $1.47 M(-22.7%) |
| Mar 2007 | - | $1.90 M(-18.4%) |
| Dec 2006 | $2.33 M(-41.1%) | $2.33 M(-15.5%) |
| Sep 2006 | - | $2.76 M(-13.1%) |
| Jun 2006 | - | $3.18 M(-11.2%) |
| Mar 2006 | - | $3.58 M(-9.7%) |
| Dec 2005 | $3.96 M(-18.6%) | $3.96 M(+3.5%) |
| Sep 2005 | - | $3.83 M(-8.2%) |
| Jun 2005 | - | $4.17 M(-7.8%) |
| Mar 2005 | - | $4.53 M(-7.1%) |
| Dec 2004 | $4.87 M(+1046.5%) | $4.87 M(+16.4%) |
| Sep 2004 | - | $4.19 M(+1192.1%) |
| Jun 2004 | - | $324.00 K(-13.5%) |
| Mar 2004 | - | $374.40 K(-11.9%) |
| Dec 2003 | $424.90 K(+63.5%) | $424.90 K(-11.3%) |
| Sep 2003 | - | $479.20 K(-13.8%) |
| Jun 2003 | - | $556.10 K(+85.9%) |
| Mar 2003 | - | $299.10 K(+15.1%) |
| Dec 2002 | $259.80 K(+102.7%) | $259.80 K(-10.6%) |
| Sep 2002 | - | $290.50 K(-14.0%) |
| Jun 2002 | - | $337.60 K(-6.4%) |
| Mar 2002 | - | $360.60 K(+442.3%) |
| Dec 2001 | $128.20 K(+20.7%) | - |
| Aug 2001 | - | $66.50 K(-17.6%) |
| May 2001 | - | $80.70 K(-13.9%) |
| Feb 2001 | - | $93.70 K(-11.8%) |
| Nov 2000 | $106.20 K(-21.8%) | $106.20 K(-40.5%) |
| Aug 2000 | - | $178.60 K(-10.8%) |
| May 2000 | - | $200.20 K(+45.3%) |
| Feb 2000 | - | $137.80 K(+1.5%) |
| Nov 1999 | $135.80 K(-47.8%) | $135.80 K(-32.3%) |
| Aug 1999 | - | $200.70 K(-80.3%) |
| May 1999 | - | $1.02 M(+91.8%) |
| Feb 1999 | - | $530.30 K |
| Nov 1998 | $260.40 K | - |
FAQ
- What is Aurinia Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual total debt year-on-year change?
- What is Aurinia Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly total debt year-on-year change?
What is Aurinia Pharmaceuticals annual total debt?
The current annual total debt of AUPH is $97.61 M
What is the all time high annual total debt for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual total debt is $97.61 M
What is Aurinia Pharmaceuticals annual total debt year-on-year change?
Over the past year, AUPH annual total debt has changed by +$89.52 M (+1106.81%)
What is Aurinia Pharmaceuticals quarterly total debt?
The current quarterly total debt of AUPH is $87.85 M
What is the all time high quarterly total debt for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly total debt is $101.21 M
What is Aurinia Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, AUPH quarterly total debt has changed by +$1.87 M (+2.17%)